Hot off the press! The Second Quarter 2009 OnBioVC | Trend Analysis study is now available for download HERE. Over $1,713M flowed into early-stage biopharma, diagnostic and device companies in 2Q09 and over $3,143M year-to-date! If you find the information in OnBioVC to be of value kindly forward on to colleagues who you believe would likewise be interested in the content. Thank you.